Geron (GERN) Consolidated Net Income (2010 - 2026)
Geron recorded quarterly Consolidated Net Income of -$3.6 million in Q1 2026, up 87.61% quarter-over-quarter from -$28.8 million in Q4 2025, and up 81.94% year-over-year from -$2.0 million in Q1 2025.
Geron's Consolidated Net Income history runs 17 years deep, the most recent figure standing at -$3.6 million for Q1 2026.
- In Q1 2026, Consolidated Net Income rose 81.94% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at -$66.9 million (up 51.16% YoY), while the FY2025 annual figure was -$83.1 million, up 51.85% from the prior year.
- Consolidated Net Income came in at -$3.6 million for Q1 2026 at Geron, up from -$28.8 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$3.6 million in Q1 2026 to a low of -$67.3 million in Q2 2024.
- A 5-year average of -$34.5 million and a median of -$30.0 million in 2022 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income slumped 68.39% in 2023 and surged 81.94% in 2026, its largest moves.
- Geron's Consolidated Net Income stood at -$42.7 million in 2022, then decreased by 21.75% to -$52.0 million in 2023, then surged by 54.63% to -$23.6 million in 2024, then fell by 22.02% to -$28.8 million in 2025, then surged by 87.61% to -$3.6 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$3.6 million, -$28.8 million, and -$18.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -8.50 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 727.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -3.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Geron | 856,799.98 | 856,799.98 | - | -3.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.57 Mn |
| Dec 31, 2025 | -28.79 Mn |
| Sep 30, 2025 | -18.27 Mn |
| Jun 30, 2025 | -16.31 Mn |
| Mar 31, 2025 | -19.75 Mn |
| Dec 31, 2024 | -23.60 Mn |
| Sep 30, 2024 | -26.38 Mn |
| Jun 30, 2024 | -67.32 Mn |
| Mar 31, 2024 | -55.33 Mn |
| Dec 31, 2023 | -52.01 Mn |
| Sep 30, 2023 | -44.71 Mn |
| Jun 30, 2023 | -49.22 Mn |
| Mar 31, 2023 | -38.16 Mn |
| Dec 31, 2022 | -42.72 Mn |
| Sep 30, 2022 | -40.91 Mn |
| Jun 30, 2022 | -29.23 Mn |
| Mar 31, 2022 | -30.04 Mn |
| Dec 31, 2021 | -32.01 Mn |
| Sep 30, 2021 | -26.62 Mn |
| Jun 30, 2021 | -29.56 Mn |
| Mar 31, 2021 | -29.02 Mn |
| Dec 31, 2020 | -23.74 Mn |
| Sep 30, 2020 | -19.70 Mn |
| Jun 30, 2020 | -16.29 Mn |
| Mar 31, 2020 | -16.16 Mn |
| Dec 31, 2019 | -29.07 Mn |
| Sep 30, 2019 | -14.99 Mn |
| Jun 30, 2019 | -14.14 Mn |
| Mar 31, 2019 | -10.16 Mn |
| Dec 31, 2018 | -8.53 Mn |
| Sep 30, 2018 | -5.80 Mn |
| Jun 30, 2018 | -6.58 Mn |
| Mar 31, 2018 | -7.06 Mn |
| Dec 31, 2017 | -7.43 Mn |
| Sep 30, 2017 | -6.90 Mn |
| Jun 30, 2017 | -6.41 Mn |
| Mar 31, 2017 | -7.18 Mn |
| Dec 31, 2016 | -8.48 Mn |
| Sep 30, 2016 | -3.58 Mn |
| Jun 30, 2016 | -8.64 Mn |
| Mar 31, 2016 | -8.84 Mn |
| Dec 31, 2015 | -8.47 Mn |
| Sep 30, 2015 | 27.19 Mn |
| Jun 30, 2015 | -9.36 Mn |
| Mar 31, 2015 | -9.33 Mn |
| Dec 31, 2014 | -8.93 Mn |
| Sep 30, 2014 | -9.84 Mn |
| Jun 30, 2014 | -8.59 Mn |
| Mar 31, 2014 | -8.66 Mn |
| Dec 31, 2013 | -9.17 Mn |
| Sep 30, 2013 | -8.05 Mn |
| Jun 30, 2013 | -8.92 Mn |
| Mar 31, 2013 | -11.92 Mn |
| Dec 31, 2012 | -15.89 Mn |
| Sep 30, 2012 | -15.91 Mn |
| Jun 30, 2012 | -18.33 Mn |
| Mar 31, 2012 | -18.77 Mn |
| Dec 31, 2011 | -30.26 Mn |
| Sep 30, 2011 | -19.81 Mn |
| Jun 30, 2011 | -21.16 Mn |
| Mar 31, 2011 | -24.09 Mn |
| Dec 31, 2010 | -58.28 Mn |
| Sep 30, 2010 | -17.93 Mn |
| Jun 30, 2010 | -16.71 Mn |